Merck to buy cancer drug developer VelosBio for $2.75 bln
11/05/2020 | 06:35am EDT
Nov 5 (Reuters) - Merck & Co Inc said on Thursday it
had agreed to acquire privately held VelosBio for $2.75 billion
in cash to expand its cancer pipeline.
(Reporting by Ankur Banerjee in Bengaluru; Editing by Sriraj